NYSEAMERICAN:INFU

InfuSystem Stock Forecast, Price & News

$18.53

-0.18 (-0.96 %)

(As of 07/28/2021 03:59 PM ET)

Add

Compare

Today's Range

$18.25

▼

$18.97

50-Day Range

$12.32

▼

$19.36

52-Week Range

$11.65

▼

$23.26

Volume1,209 shs

Average Volume100,504 shs

Market Capitalization$379.29 million

P/E Ratio21.80

Dividend YieldN/A

Beta0.96

30 days | 90 days | 365 days | Advanced Chart

Receive INFU News and Ratings via Email

Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter.

About InfuSystem

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates through two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) Services. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

InfuSystem Holdings Inc. (NYSEAMERICAN:INFU) Short Interest Update
July 18, 2021 | americanbankingnews.com

InfuSystem Announces $20 Million Stock Repurchase Program - Yahoo Finance
July 2, 2021 | finance.yahoo.com

72 Biggest Movers From Yesterday Gainers Pop Culture Group Co., Ltd - Benzinga
July 1, 2021 | benzinga.com

Infusystem Hldgs, Inc. (INFU) Announces $20M Share Buyback - StreetInsider.com
June 30, 2021 | streetinsider.com

InfuSystem Announces $20 Million Stock Repurchase Program - GlobeNewswire
June 30, 2021 | globenewswire.com

InfuSystem Announces $20 Million Stock Repurchase Program
June 30, 2021 | finance.yahoo.com

InfuSystem Enters Lymphedema Therapy Market - GlobeNewswire
June 29, 2021 | globenewswire.com

InfuSystem Enters Lymphedema Therapy Market
June 29, 2021 | finance.yahoo.com

InfuSystem to Participate at Craig-Hallum 18th Annual Institutional Investor Conference June 2, 2021 - GlobeNewswire
May 27, 2021 | globenewswire.com

Nuvve Announces New Start Time for First Quarter 2021 Financial Results Conference Call at 9:00 AM ET on Monday, May 17, 2021 - Yahoo Finance
May 14, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:INFU
Previous SymbolNYSE:INFU
CUSIPN/A
CIK1337013
Webir.infusystem.com
Phone+1-248-2911210
Employees282
Year FoundedN/A

Sales & Book Value

Annual Sales$97.39 million
Price / Sales3.89
Cash Flow$1.52 per share
Price / Cash Flow12.16
Book Value$2.01 per share
Price / Book9.22

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares20,469,000
Market Cap$379.29 million
Next Earnings Date8/12/2021 (Estimated)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

2.36 out of 5 stars

Medical Sector

101st out of 2,210 stocks

Surgical & Medical Instruments Industry

8th out of 185 stocks

3.5 Analyst's Opinion

Consensus Rating
InfuSystem has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $27.00, InfuSystem has a forecasted upside of 45.7% from its current price of $18.53.
Amount of Analyst Coverage
InfuSystem has only been the subject of 1 research reports in the past 90 days.

3.3 Community Rank

Outperform Votes
InfuSystem has received 87 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
InfuSystem has received 46 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
InfuSystem has received 65.41% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about InfuSystem and other stocks. Vote “Outperform” if you believe INFU will outperform the S&P 500 over the long term. Vote “Underperform” if you believe INFU will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
InfuSystem does not currently pay a dividend.
Dividend Growth
InfuSystem does not have a long track record of dividend growth.

2.5 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, InfuSystem insiders have not sold or bought any company stock.
Percentage Held by Insiders
18.20% of the stock of InfuSystem is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
61.55% of the stock of InfuSystem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5 Earnings and Valuation

Earnings Growth
Earnings for InfuSystem are expected to grow by 14.71% in the coming year, from $0.34 to $0.39 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of InfuSystem is 21.80, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 22.19.
Price to Earnings Ratio vs. Sector
The P/E ratio of InfuSystem is 21.80, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 37.02.
Price to Book Value per Share Ratio
InfuSystem has a P/B Ratio of 9.22. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

InfuSystem (NYSEAMERICAN:INFU) Frequently Asked Questions

Is InfuSystem a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for InfuSystem in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" InfuSystem stock.
View analyst ratings for InfuSystem or view top-rated stocks.

What stocks does MarketBeat like better than InfuSystem?

Wall Street analysts have given InfuSystem a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but InfuSystem wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting InfuSystem?

InfuSystem saw a decline in short interest in the month of July. As of July 15th, there was short interest totaling 249,200 shares, a decline of 28.7% from the June 30th total of 349,600 shares. Based on an average daily volume of 90,800 shares, the short-interest ratio is currently 2.7 days. Currently, 1.4% of the shares of the stock are short sold.
View InfuSystem's Short Interest.

When is InfuSystem's next earnings date?

InfuSystem is scheduled to release its next quarterly earnings announcement on Thursday, August 12th 2021.
View our earnings forecast for InfuSystem.

How were InfuSystem's earnings last quarter?

InfuSystem Holdings Inc. (NYSEAMERICAN:INFU) released its quarterly earnings results on Thursday, May, 6th. The medical instruments supplier reported $0.03 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.04 by $0.01. The medical instruments supplier had revenue of $24.46 million for the quarter, compared to analyst estimates of $24.50 million. InfuSystem had a trailing twelve-month return on equity of 52.87% and a net margin of 18.36%.
View InfuSystem's earnings history.

What guidance has InfuSystem issued on next quarter's earnings?

InfuSystem issued an update on its FY 2021 earnings guidance on Thursday, May, 27th. The company provided earnings per share (EPS) guidance of - for the period. The company issued revenue guidance of $107 million-$110 million, compared to the consensus revenue estimate of $108.97 million.

What price target have analysts set for INFU?

3 analysts have issued twelve-month price targets for InfuSystem's stock. Their forecasts range from $26.00 to $28.00. On average, they anticipate InfuSystem's share price to reach $27.00 in the next year. This suggests a possible upside of 45.7% from the stock's current price.
View analysts' price targets for InfuSystem or view top-rated stocks among Wall Street analysts.

Who are InfuSystem's key executives?

InfuSystem's management team includes the following people:

Mr. Richard A. DiIorio, CEO & Director (Age 46, Pay $1.06M)
Ms. Carrie Lachance B.S.N., R.N., Pres, COO & Director (Age 44, Pay $468.25k)
Mr. Barry G. Steele, Exec. VP & CFO (Age 50, Pay $475.12k)
Ms. Jeannine Lombardi Sheehan, Exec. VP & Chief Admin. Officer (Age 47)
Mr. Thomas Mark Ruiz, Exec. VP & Chief Commercial Officer (Age 63)
Jeanie Latz, Corp. Sec.

Who are some of InfuSystem's key competitors?

Some companies that are related to InfuSystem include Pulmonx (LUNG), Alphatec (ATEC), MiMedx Group (MDXG), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Atrion (ATRI), LeMaitre Vascular (LMAT), CryoLife (CRY), AngioDynamics (ANGO), SI-BONE (SIBN), Bioventus (BVS), Tactile Systems Technology (TCMD), Cerus (CERS), Nyxoah (NYXH) and OraSure Technologies (OSUR).
View all of INFU's competitors.

What other stocks do shareholders of InfuSystem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other InfuSystem investors own include Macquarie Infrastructure (MIC), Ampio Pharmaceuticals (AMPE), Second Sight Medical Products (EYES), Navidea Biopharmaceuticals (NAVB), Otelco (OTEL), Pershing Gold (PGLC), Palatin Technologies (PTN), AgroFresh Solutions (AGFS), Advanced Micro Devices (AMD) and Digital Turbine (APPS).

What is InfuSystem's stock symbol?

InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."

How do I buy shares of InfuSystem?

Shares of INFU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is InfuSystem's stock price today?

One share of INFU stock can currently be purchased for approximately $18.53.

How much money does InfuSystem make?

InfuSystem has a market capitalization of $379.29 million and generates $97.39 million in revenue each year. The medical instruments supplier earns $17.33 million in net income (profit) each year or $0.80 on an earnings per share basis.

How many employees does InfuSystem have?

InfuSystem employs 282 workers across the globe.

What is InfuSystem's official website?

The official website for InfuSystem is ir.infusystem.com.

Where are InfuSystem's headquarters?

InfuSystem is headquartered at 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States.

How can I contact InfuSystem?

InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier can be reached via phone at +1-248-2911210.

This page was last updated on 7/28/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here